Lupin 2024

Albert Thigpen

Diplomat provides updated 2018 guidance and preliminary 2019 outlook

Diplomat provides updated 2018 guidance and preliminary 2019 outlook

FLINT, Mich. — Diplomat Pharmacy is updating its 2018 financial guidance and providing a preliminary 2019 outlook in connection with its presentation today at the JP Morgan Healthcare Conference in San Francisco. Diplomat now expects 2018 revenue to be at the lower end of the previously communicated $5.5 to $5.7 billion range and adjusted EBITDA to be at

Diplomat launches CastiaRx, leading specialty benefit manager

Diplomat launches CastiaRx, leading specialty benefit manager

FLINT, Mich. — Diplomat Pharmacy has unveiled CastiaRx to respond to industry demand for a leader in specialty benefit management. CastiaRx unites the full-service pharmacy benefit manager (PBM) capabilities of recently acquired LDI Integrated Pharmacy Services and National Pharmaceutical Services with Diplomat’s specialty pharmacy and infusion expertise. According to the IQVIA Institute for Human Data

Diplomat wraps up acquisition of LDI

Diplomat wraps up acquisition of LDI

FLINT, Mich. — Diplomat Pharmacy Inc. has closed its $595 million acquisition of pharmacy benefit manager LDI Integrated Pharmacy Services. With the completion of the cash-and-stock deal, Diplomat also announced that it has obtained $800 million in senior secured credit facilities. The proceeds of the debt financing will be used to finance the LDI acquisition, pay related transaction fees and

Diplomat Pharmacy buys LDI for $595 million

Diplomat Pharmacy buys LDI for $595 million

FLINT, Mich. — Diplomat Pharmacy Inc. plans to acquire St. Louis-based pharmacy benefit manager LDI Integrated Pharmacy Services for in a $595 million cash and stock deal. The move marks the second PBM acquisition this month by Diplomat, the nation’s largest independent specialty pharmacy. On Nov. 6, the company announced the purchase of National Pharmacy

PP_1170x120_10-25-21